Actively Recruiting
Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN
Led by University Hospital, Bordeaux · Updated on 2025-02-10
200
Participants Needed
1
Research Sites
523 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study proposes to describe and evaluate the rate of spontaneous regression of CIN2 at 2 year of follow up in women between 18 and 39 year old. This follow-up is proposed as an alternative to the treatment of reference (conization) with a possible extension to 4 years
CONDITIONS
Official Title
Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN
Who Can Participate
Eligibility Criteria
You may qualify if you...
- CIN2 confirmed by biopsy, age between 18 and 39 years
- Satisfactory colposcopy identifying the junction and the lesion
- Affiliated person or beneficiary of a social security scheme
- Given oral agreement and authorization for data processing
You will not qualify if you...
- Current pregnancy
- History of conization
- Atypical or atypical glandular cells or cancer found during smear
- Prophylactic vaccination against HPV
- Active systemic infection requiring treatment
- History of HIV infection, congenital or acquired immunodepression
- Long-term corticosteroid or immunosuppressant treatment
- Under legal protection (safeguard of justice)
- Non-compliance with protocol requirements, including lack of long-term follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Bordeaux
Bordeaux, France
Actively Recruiting
Research Team
J
Jean-Luc Brun, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here